(Q47916563)

6 February 2018

title

Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium). (English)

1 reference

6 February 2018

0 references

1 reference

1 reference

1 reference

3

1 reference

6 February 2018

Pierre Van Damme

series ordinal

2

object named as

Pierre Van Damme

1 reference

6 February 2018

5

Claire-Anne Siegrist

1 reference

6 February 2018

author name string

Marie Van der Wielen

series ordinal

1

1 reference

6 February 2018

Susanna Schlegel-Haueter

series ordinal

4

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 June 2003

1 reference

6 February 2018

published in

Vaccine

1 reference

6 February 2018

volume

21

1 reference

6 February 2018

issue

19-20

1 reference

6 February 2018

page(s)

2412-2417

1 reference

6 February 2018

Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Pertussis immunisation in Europe - the situation in late 1999

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Prevalence of hepatitis A, B and C in the Flemish population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Diphtheria immunity in Flanders

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

The return of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Pertussis and its prevention: a family affair

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Pertussis: current concepts of pathogenesis and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Distribution of pertussis antibodies among different age groups in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Intrafamilial spread of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Return of epidemic pertussis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

Prevalence of markers of exposure to Bordetella pertussis among Italian young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900062-8

7 January 2021

10.1016/S0264-410X(03)00062-8

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018